www.sionnatx.comHealthcare / BioTech & PharmaFounded: 2019Funding to Date: $331.32MM
Sionna Therapeutics is a life science company that aims to develop treatments for cystic fibrosis, which is a genetic disorder that affects the functioning of the lungs, pancreas, and other organs. Sionna Therapeutics was founded in 2019 and is headquartered in Boston, MA. The company researches drug treatments for the disorder striving to restore the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The CFTR protein is essential for the regulation of salt and water balance in the body.
View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Sionna Therapeutics.
Become part of the Secondary Marketplace, catering to both individual and institutional investors.